Comments
Ajanta Pharma’s share price has a sharp decline over the past few sessions. It fell off the hurdle at ₹1,850 last week and on Monday, the stock closed below a support at ₹1,700. Even though the price went up on Wednesday, the weakness persists, and the rally is likely to be a corrective one.
So, this can be considered as an opportunity to initiate short positions. Irrespective of the overall trend, which still remains bullish, the price action indicates a potential drop in price, particularly on Thursday. We expect an intraday decline to ₹1,620. So, traders can go short on the stock of Ajanta Pharma for intraday. Short at the current level of ₹1,701 and place a stop-loss at ₹1,740. Book profits at ₹1,620.
(Note: The recommendations are based on technical analysis. There is a risk of loss in trading.)
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.